Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Does ATP cause Annexin A5 targeting in the human forearm?
2007-005893-29Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of adenosine 5'-triphosphate in atherosclerosis (3 arms), sponsored by Radboud University Medical Center. Primary endpoints: Primary endpoint at 60 minutes and Primary endpoint at 240 minutes. Started Oct 2007; status: completed.
02
Drugs
adenosine 5'-triphosphate
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on 2007-005893-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005893-29.